Understanding iDose® TR: A Breakthrough in Glaucoma Treatment thumbnail

Understanding iDose® TR: A Breakthrough in Glaucoma Treatment

Published Nov 29, 24
1 min read


iDose® TR marks a significant breakthrough in the treatment of glaucoma, delivering a long-term and efficient method for managing intraocular pressure (IOP). Unlike traditional eye drops that demand frequent use, iDose® TR is a tiny, implantable device crafted to provide a controlled dispensation of treatment directly into the eye over an longer period. This cutting-edge approach removes the hassle of daily applications, dramatically boosting patient adherence and overall treatment effectiveness.

At Eye Center South, we are honored to introduce iDose® TR as part of our holistic glaucoma care. The device is placed during a simple and low-risk procedure, ensuring patient comfort and convenience. Once in place, it delivers a steady dose of the prescribed medication, working to stabilize intraocular pressure and ensuring your visual health. Patients who struggle with the challenges of daily eye drop regimens can benefit greatly from this next-generation treatment.



Visit for more info At Eye Center South